Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Chronic prostatitis/chronic pelvic pain syndrome continues to pose a treatment challenge for urologists. Most commonly prescribed medications, such as antibiotics, α-blockers, androgen inhibitors, and anti-inflammatory agents, have been shown to help some patients. However, the efficacy and durability of such treatments lack consistency among men suffering from this disorder. The rationale for such treatments is described in this article, along with possible explanations for the apparent shortcomings. Also included is a brief summary of alternative therapies, which are growing in popularity among patients and gaining acceptance in our medical communities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Turner JA, Ciol MA, Von Korff M, et al.: Healthcare use and costs of primary and secondary care patients with prostatitis. Urology 2004, 63:1031–1035.

    Article  PubMed  Google Scholar 

  2. Nickel JC: Recommendations for the evaluation of patients with prostatitis. World J Urol 2003, 21:75–81.

    Article  PubMed  Google Scholar 

  3. Nickel JC, Downey J, Ardern D: Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:551–554. The observations shared by the authors are rich with patient volume and diverse treatment experience. It validates the varied responses to therapy in this patient population seen in clinical practice.

    Article  PubMed  Google Scholar 

  4. International Prostatitis Collaborative Network: Proceedings of the NIH/NIDDK meeting on Prostatitis, 1998.

  5. Nickel JC, Alexander RB, Schaeffer AJ, et al.: Bacteria localizator does not correlate to symptoms and localization prevalence in indisting work in CP/CPPS versus controls. J Urol 2003.

  6. Nickel JC, Downey J, Clark J, et al.: Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized, placebo-controlled, multicenter trail. Urology 2003, 62:614–617.

    Article  PubMed  Google Scholar 

  7. Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann Intern Med 2004, 141:581–589.

    PubMed  CAS  Google Scholar 

  8. Wagenlehner FM, Naber KG: Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther 2003, 1:275–282.

    Article  PubMed  Google Scholar 

  9. Evliyaoglu Y, Burgut R: Lower urinary tract symptoms, pain, and quality-of-life assessment in chronic non-bacterial prostatitis patients treated with a-blocking agent doxazosin versus placebo. Int Urol Nephrol 2002, 34:351–356.

    Article  PubMed  CAS  Google Scholar 

  10. Gül O, Eroglu M, Özok U: Use of terazosin in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 2001, 32:433–436.

    Article  PubMed  Google Scholar 

  11. Mehik A, Alas P, Nickel JC: Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003, 62:425–429.

    Article  PubMed  Google Scholar 

  12. Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized, double-blind trial. J Urol 2004, 171:1594–1597.

    Article  PubMed  CAS  Google Scholar 

  13. Pontari MA: Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology 2002, 60(suppl):29–34.

    Article  Google Scholar 

  14. Seo SI, Lee SJ, Kim JC, et al.: Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol 2003, 10:485–491.

    Article  PubMed  CAS  Google Scholar 

  15. De Rose AF, Gallo F, Giglio M, Carmignani G: Role of mepartricin in category-III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, prospective, placebo-controlled trial. Urology 2004, 63:13–16.

    Article  PubMed  Google Scholar 

  16. Nickel JC, Downey J, Pontari MA, et al.: A randomized, placebo-controlled, multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93:991–995.

    Article  PubMed  CAS  Google Scholar 

  17. Mehik A, Hellstrom P, Nickel C: Chronic prostatitis/chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2001, 167:137–140.

    Article  Google Scholar 

  18. Potts JM: Prospective identification of national institutes of health category-IV prostatitis in men with elevated prostate specific antigen. J Urol 2000, 164:1550–1553.

    Article  PubMed  CAS  Google Scholar 

  19. Hochreiter W, Nadler R, Koch A: Diagnostic value of serial cytokine changes in expressed prostatic secretions [Abstract 105]. J Urol 2000, 163:24.

    Article  Google Scholar 

  20. Shahed A, Shoskes D: Correlation of beta-endorphin and prostaglandin E2 in prostatic fluid of patients with chronic prostatitis with diagnostic treatment response. J Urol 2001, 166:1738–1741.

    Article  PubMed  CAS  Google Scholar 

  21. Weiss J: Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2000, 166:2226–2231.

    Article  Google Scholar 

  22. Shoskes DA: Phytotherapy in chronic prostatitis. Urology 2002, 60(suppl):35–37.

    Article  PubMed  Google Scholar 

  23. Chen RC, Nickel JC: Acupuncture for chronic prostatitis/ chronic pelvic pain syndrome. Curr Urol Rep 2004, 5:305–308.

    Article  PubMed  Google Scholar 

  24. Millea PJ, Holloway R: Treating fibromyalgia. Am Fam Physician 2000, 62:1575–1582.

    PubMed  CAS  Google Scholar 

  25. Anderson RU: Management of chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am 2002, 29:235–239.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glickman Urological Institute, 9500 Euclid Avenue, A/100, 44195, Cleveland, OH, USA

    Jeannette M. Potts MD

Authors
  1. Jeannette M. Potts MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potts, J.M. Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 6, 313–317 (2005). https://doi.org/10.1007/s11934-005-0030-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-005-0030-5

Keywords

Search

Navigation